Registry of Lobbyists
Total Number of Communication Reports: 25
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Industry
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a priority of the government.
|
Policies or Program
|
|
Health, Industry
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
|
Policies or Program
|
|
Health
|
Engagement with officials regarding Health Canada’s proposed development of a strategy for drugs for rare disorders and other aspects of national pharmacare, including proposals for a Canada Drug Agency and a national formulary
|
Policies or Program
|
|
Health, Industry
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Policies or Program, Regulation
|
|
Health
|
Health Canada Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements) (SOR/2019-298) published in the Canada Gazette Part 2 on August 21, 2019
|
Regulation
|
Address:
350 Bay St, Suite 700 Toronto, ON M5H 2S6
Toronto, ON M5H 2S6
Canada
Telephone number:
416-426-7293
Jason Field, President & CEO
Life Sciences Ontario is not a subsidiary of any other parent companies.
Life Sciences Ontario is not a coalition.
The activities of Life Sciences Ontario are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Life Sciences Ontario does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Philip Delistoyanov | No public offices held
Firm: 3Sixty Public Affairs